Michael A. Smith - 13 May 2025 Form 4 Insider Report for INSMED Inc (INSM)

Reporting relationship: Chief Legal Officer
Issuer ticker: INSM
Reported as of: 13 May 2025
Net transaction value: -$325,673
SEC form: 4
Accepted by SEC: 15 May 2025, 16:36:05 UTC
Prior SEC filing: 07 Feb 2025
Next SEC filing: 19 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Michael A. Smith

Key filing fact

Michael A. Smith filed Form 4 for INSMED Inc (INSM) on 15 May 2025.

Key facts

This page summarizes Michael A. Smith's Form 4 filing for INSMED Inc (INSM).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 15 May 2025, 16:36.

Change

Previous filing in this sequence was filed on 07 Feb 2025.
Current net transaction value: -$325,673.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001870278 Primary reporting owner

Smith Michael Alexander

Relationship: Chief Legal Officer
Address: 700 US HIGHWAY 202/206, BRIDGEWATER
Signature: /s/ Michael A. Smith
Signature date: 15 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INSM transaction

Common Stock

Sale

Transaction value: $298,839
Shares: -4,407
Change %: -4.6%
Price: $67.81
Shares after: 92,203
Date: 13 May 2025
Ownership: Direct
Footnotes: F1

INSM transaction

Common Stock

Sale

Transaction value: $26,834
Shares: -409
Change %: -0.44%
Price: $65.61
Shares after: 91,794
Date: 14 May 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .